Molecular portraits of tumor mutational and micro-environmental sculpting by immune checkpoint blockade therapy
Ontology highlight
ABSTRACT: Immune checkpoint blockade (ICB) has demonstrated significant promise for the treatment of advanced malignancies. Anti-CTLA4 and ant-PD1 therapy can activate the immune system and result in durable control in diseases such as melanoma and non-small cell lung cancer.
ORGANISM(S): Homo sapiens
PROVIDER: GSE91061 | GEO | 2018/01/23
REPOSITORIES: GEO
ACCESS DATA